Articles From: ARM HPC Ecosystem Continues to Build Momentum with Introduction of PathScale EKOPath Compiler to Array BioPharma Appoints Victor Sandor, M.D., As Chief Medical Officer


ARM ecosystem partner PathScale today announced the upcoming availability of its EKOPath Compiler for ARM ® -based servers in high-performance computing (HPC) applications.
Sign-up for ARM HPC Ecosystem Continues to Build Momentum with Introduction of PathScale EKOPath Compiler investment picks
ARM has unveiled a new 32-bit Cortex-M processor that delivers double the compute and digital signal processing (DSP) capability of today’s most powerful ARM-based MCUs.
Sign-up for ARM Supercharges MCU Market with High Performance Cortex-M7 Processor investment picks
Armada Hoffler Properties, Inc. (NYSE: AHH) (the "Company") today announced that it has commenced an underwritten public offering of 5,000,000 shares of its common stock.
Sign-up for Armada Hoffler Properties Announces Commencement of Public Offering of Common Stock investment picks
Armada Hoffler Properties, Inc. (NYSE:AHH), today announced that its Board of Directors declared a dividend of $0.16 per share on the Company's shares of common stock for the fourth quarter of 2014.
Sign-up for Armada Hoffler Properties Announces Dividend for Fourth Quarter 2014 investment picks
Armada Hoffler Properties, Inc. (NYSE: AHH) (the "Company") today announced that it has priced an underwritten public offering of 5,000,000 shares of its common stock at a public offering price of $9.05 per share, for net proceeds, after the underwriting discount but before estimated expenses of the offering payable by the Company, of approximately $43.1 million.
Sign-up for Armada Hoffler Properties Pricing of Public Offering of Common Stock investment picks
Armada Hoffler Properties, Inc. (NYSE: AHH), a full service real estate company that develops and owns high-quality office, retail and multifamily properties in key Mid-Atlantic markets, today announced its results for the quarter ended September 30, 2014.
Sign-up for Armada Hoffler Properties Reports Third Quarter 2014 Results investment picks
Armada Hoffler Properties, Inc. (NYSE: AHH) will report its earnings for the third quarter ended September 30, 2014 at approximately 6:00 a.m. Eastern Time on Friday, October 31, 2014.
Sign-up for Armada Hoffler Properties to Discuss Third Quarter Earnings on October 31st investment picks
2014/12/4
Armanino Foods of Distinction, Inc. (OTC Pink: AMNF) announced today that its board of directors has declared its regular quarterly cash dividend of $0.018 per share payable to shareholders of record January 2, 2015.
Sign-up for Armanino Foods of Distinction, Inc. Announces Regular Quarterly Dividend investment picks
2014/9/11
Armanino Foods of Distinction, Inc. (OTC Pink:AMNF) today declared an increased regular quarterly dividend of $0.018 per share.
Sign-up for Armanino Foods of Distinction, Inc. Raises Its Regular Quarterly Dividend by 12.5% investment picks
2014/10/17
Armanino Foods of Distinction, Inc. (OTC Pink: AMNF) reported the highest quarterly sales and earnings in its history.
Sign-up for Armanino Foods of Distinction, Inc. Reports Highest Quarterly Sales (+18%) and Income (+29%) in its History investment picks
2014/10/28
VERO BEACH, Fla.
Sign-up for ARMOUR Residential REIT, Inc. Third Quarter Webcast Scheduled For October 30, 2014 investment picks
Armstrong World Industries (AWI) said Monday its full-year sales and EBITDA --
Sign-up for Armstrong World Industries warns sales, EBITDA will miss guidance investment picks
2014/10/15
Armtec Infrastructure Inc. Announces Satisfaction of Conditions for Settlement of Proposed Class Actions Canada NewsWire As previously disclosed, this settlement provides for a payment in the amount of approximately Cdn.
Sign-up for Armtec Infrastructure Inc. Announces Satisfaction of Conditions for Settlement of Proposed Class Actions investment picks
2014/10/29
Armtec Infrastructure Inc. to Hold 2014 Third Quarter Results Conference Call Canada NewsWire Toronto Stock Exchange: ARF; ARF.DB CONCORD, ON , Oct.
Sign-up for Armtec Infrastructure Inc. to Hold 2014 Third Quarter Results Conference Call investment picks
2014/11/11
Armtec Reports Financial Results for the Third Quarter 2014 Canada NewsWire Toronto Stock Exchange: ARF; ARF.DB CONCORD, ON , Nov.
Sign-up for Armtec Reports Financial Results for the Third Quarter 2014 investment picks
2014/12/1
Scottsdale resident Dan Cavanaugh had even more to be thankful for this Thanksgiving as he recently was handed the keys to the HGTV Urban Oasis® 2014 , an All-New 2015 Acura TLX and $50,000, provided by national mortgage lender Quicken Loans.
Sign-up for Army Veteran from Scottsdale Wins Grand Prize in HGTV Urban Oasis 2014 Giveaway investment picks
2014/11/3
Ingersoll Rand , a global leader in compressed air systems and services, power tools, and fluid and material handling equipment, expands its line of smart solutions from ARO ® with the new SD line of FDA-compliant diaphragm pumps.
Sign-up for ARO® Introduces Series of FDA-Compliant Diaphragm Pumps investment picks
2014/11/10
Revenues, operating profit, EBITDA and net profit for 2014 all continue up; 2014 EBITDA guidance again increased ANN ARBOR, Mich.
Sign-up for Arotech Corporation Reports Results For The Third Quarter And First Nine Months, 2014 investment picks
2014/11/24
ANN ARBOR, Michigan , November 24, 2014 /PRNewswire/ -- Arotech Corporation [Nasdaq GM: ARTX] announced today that it has purchased shares under its share buy-back program, which was originally approved by the Board of Directors in 2009 and expanded and extended in August 2014 .
Sign-up for Arotech Recommences its Share Buy Back Program investment picks
2014/10/23
- Conference Call Scheduled for Tuesday, November 11, 2014 at 9:00am Eastern Time - ANN ARBOR, Michigan , October 23, 2014 /PRNewswire/ -- Arotech Corporation (NasdaqGM: ARTX), a provider of quality defense and security products for the military, law enforcement and homeland security markets, announced that it will be releasing its third quarter 2014 results on Monday, November 10, 2014 after the US markets close.
Sign-up for Arotech Schedules Third Quarter 2014 Results Release for Monday, November 10, 2014 investment picks
ANN ARBOR, Michigan , December 2, 2014 /PRNewswire/ -- Arotech Corporation [Nasdaq GM: ARTX] announced today that it will be relocating the operations of its Electric Fuel Battery Corporation (EFB) subsidiary from Auburn, Alabama to Arotech's cutting-edge engineering and manufacturing facilities in Charleston, South Carolina , beginning early in 2015.
Sign-up for Arotech to Combine Its Power Systems Division's U.S. Facilities Into One Location in South Carolina investment picks
ANN ARBOR, Mich.
Sign-up for Arotech Training And Simulation Division Announces $9.1 Million In New Orders investment picks
BETHESDA, Md., Oct.
Sign-up for Around the World It's Agreed: Marriott International is a Great Place to Work investment picks
ArQule, Inc. (NASDAQ: ARQL) today announced an agreement with the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH) providing for the clinical development of ARQ 092, an orally available, selective small molecule inhibitor of AKT, in Proteus syndrome, a rare disease characterized by overgrowth of the skeleton, skin, adipose tissue and central nervous system.
Sign-up for ArQule Announces Collaboration with NIH for Clinical Development of ARQ 092 in Proteus Syndrome investment picks
ArQule, Inc. (Nasdaq: ARQL) today announced that eight presentations of clinical and pre-clinical data on three early clinical-stage product candidates will take place during the 26 th EORTC-NCI-AACR Symposium to be held November 18-21, 2014 in Barcelona, Spain.
Sign-up for ArQule Announces Data Presentations with Pipeline Products to Be Featured at 26th EORTC-NCI-AACR Symposium investment picks
ArQule, Inc. (NASDAQ: ARQL) today announced positive top-line results from a randomized, double-blind, placebo-controlled Phase 2 clinical trial of tivantinib as a single agent in metastatic prostate cancer.
Sign-up for ArQule Announces Positive Top-Line Results of NIH-Sponsored Phase 2 Trial of Tivantinib in Prostate Cancer investment picks
ArQule, Inc. (NASDAQ: ARQL) today reported its results of operations for the fiscal quarter and nine months ended September 30, 2014.
Sign-up for ArQule Announces Third Quarter Fiscal 2014 Results investment picks
ArQule, Inc. (NASDAQ: ARQL) today announced that it will report its financial results for the third quarter of 2014 on Monday, November 10, 2014 at 7:00 a.m. Eastern Time.
Sign-up for ArQule to Report Third Quarter 2014 Financial Results on November 10, 2014 investment picks
Clinical oncology expert joins as company advances late-stage clinical programs BOULDER, Colo.
Sign-up for Array BioPharma Appoints Victor Sandor, M.D., As Chief Medical Officer investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: ARM HPC Ecosystem Continues to Build Momentum with Introduction of PathScale EKOPath Compiler to Array BioPharma Appoints Victor Sandor, M.D., As Chief Medical Officer
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent